Gleneagles has launched its Gleneagles Clinical Trials Centre (Gleneagles CTC) on September 19, 2024, marking an important milestone in our commitment to advancing medical research and patient care. Co-managed by Gleneagles Hospital Hong Kong and HKU Clinical Trials Centre, Gleneagles CTC provides a platform for innovative discovery across the clinical research ecosystem and facilitates various types of clinical research and studies on treatments, procedures, drugs, vaccines, medical devices, and more.
As the city’s first private hospital operating a clinical trials centre in partnership with the LKS Faculty of Medicine of The University of Hong Kong (HKUMed) and one of HKUMed’s research sites, Gleneagles aspires to go beyond providing high-quality and personalised care for patients, but also to drive cutting-edge clinical trials to advance treatment and evidence-based care.
Through Gleneagles CTC, we look forward to achieving more impactful clinical research outcomes which will in turn bring innovative treatments and new hope to more patients.
